Delivery Order SPE2DB20D7059-SPE2DB24FPYP0

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The $3,679.40 contract is for the supply of phytonadione 1 mg/0.5 ml syrups. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of phytonadione 1 mg/0.5 mL syringes. The contract has a ceiling value of $11,602.64 and a period of performance through December 4, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is valued at $5,659.98 and is for the delivery of the pharmaceutical product phytonadione 1 mg/0.5 mL syringe, 0.5 mL. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,289.64, is for the delivery of 4,567,442,998 units of the medication phytonadione 1 mg/0.5 ml syringe. The contract has a firm fixed price and an ultimate completion date of March 4, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product Phytonadione 1 mg/0.5 ml syringe 0.5 ml. The contract, valued at $3,354.54, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. It is a firm-fixed-price contract with a completion date of May 22, 2024. The contract is not set aside for any particular business type. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award is for the delivery of Phytonadione 1 mg/0.5 ml syringe 0.5 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,698.17, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide a...
This is a firm-fixed price delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of phytonadione 1 mg/0.5 ml syrup. The award, valued at $2,340.42, has an ultimate completion date of March 10, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, Phytonadione 1 mg/0.5 ml Syringe, 0.5 ml, with a ceiling value of $5,788.51 and a completion date of November 12, 2024. The contract is not designated as a set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Phytonadione 1 mg/0.5 ml syrup, a specialty pharmaceutical product. The contract has a ceiling value of $7,889.06 and an ultimate completion date of December 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,405.51, is for the delivery of Phytonadione 1 mg/0.5 ml syrup in 0.5 ml quantities. The contract has a period of performance through December 27, 2023 and is a firm-fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FPYP0
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 0.5 mL syringes of phytonadione 1 mg. The contract has a potential value of $2,046.70 and a completion date of February 2, 2024. This award is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation.

Generated 5/2/24, 10:21 AM